CClinicalTrials.gg
RecruitingNCT05675618Updated Feb 13, 2026

Return to Golf After Orthopaedic Surgery

An observational study in Hip Osteoarthritis, Knee Osteoarthritis and Shoulder Osteoarthritis, sponsored by Hospital for Special Surgery, New York. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-13.

Sponsored by Hospital for Special Surgery, New York · Observational

From the registry’s dates

  • Started Jan 2023; still recruiting 3 years 8 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
432
Ages
18 Years and older
Sex
All
01

Study summary

The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery. Participants in this study must have a desire to return to golf after surgery. Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.

02

Conditions studied

  • Hip Osteoarthritis
  • Knee Osteoarthritis
  • Shoulder Osteoarthritis

Keywords

  • return to golf, arthroplasty
03

In context

Osteoarthritis, Hip

628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.

This study's planned enrollment of 432 is above the median of 141 across 154 observational studies indexed under Osteoarthritis, Hip.

Browse Osteoarthritis, Hip studies →

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 218 studies on the registry; 40 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 20 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients undergoing joint replacement surgery who are self-reported golfers and have a desire to return to golf postoperatively

Inclusion criteria

  • Age 18+ years
  • A self-reported golfer
  • Able to consent to treatment
  • Indicated for one of the following surgical procedures: total hip arthroplasty, hip resurfacing, revision hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, revision knee arthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, shoulder resurfacing arthroplasty, revision shoulder arthroplasty

Exclusion criteria

Exclusion Criteria:

  • Inability to complete follow-up questionnaires
  • Declining operative management
  • No desire to return to golf postoperatively
  • Medical problem that affects the patient's ability to play golf (e.g., angina, shortness of breath, etc.)
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
432 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Prevalence of return to golf following joint arthroplasty

    Patients will be asked if they have returned to golf (putting, chipping, 9 holes, 18 holes, etc) following joint arthroplasty.

    Time frame: Up to 1 year postoperatively

Secondary outcomes

  1. Golf awareness after arthroplasty score

    This questionnaire assesses awareness of the joint replacement while playing golf and engaging in specific golf activities. A higher score represents more awareness, whereas a lower score represents less awareness.

    Time frame: Up to 1 year postoperatively

  2. Hip Disability and Osteoarthritis Outcome Score for Joint Replacement (HOOS JR)

    The HOOS JR measures overall hip health on a scale of 0-100, where 0 represents total hip disability and 100 represents perfect hip health. This will be administered specifically to patients undergoing hip arthroplasty.

    Time frame: Up to 1 year postoperatively

  3. Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR)

    The KOOS JR measures overall knee health on a scale of 0-100, where 0 represents total knee disability and 100 represents perfect knee health. This will be administered specifically to patients who undergo knee arthroplasty.

    Time frame: Up to 1 year postoperatively

  4. American Shoulder and Elbow Surgeons Shoulder Score (ASES)

    The ASES measures shoulder function on a scale of 0-100, where 0 represents worse function and 100 represents best function. This will be administered specifically to patients who undergo shoulder arthroplasty.

    Time frame: Up to 1 year postoperatively

07

Study locations

2 of 2 sites recruiting
  • Hospital for Special Surgery
    New York, New York 10021, United States
    • Andrew Creighton · Contact
    Recruiting
  • Royal Infirmary of Edinburgh
    Edinburgh, United Kingdom
    • Patrick Robinson · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05675618
Lead sponsor
Hospital for Special Surgery, New York
Collaborators
Royal Infirmary of Edinburgh
Responsible party
Sponsor
First posted
Jan 9, 2023
Start date
Jan 9, 2023
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Feb 13, 2026

Study contacts

Andrew Creighton, DO
Contact
creightona@hss.edu
646-344-4340
Jennifer Cheng
Contact
chengj@hss.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion